Fig. 1 · Structure
Documents & Downloads
ALC-0159
Vaccine Excipient
ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that serves as a vaccine excipient. Its incorporation enhances the stability and delivery of vaccine formulations by facilitating the encapsulation of active pharmaceutical ingredients. ALC-0159 is particularly useful in the development of lipid nanoparticles and other innovative drug delivery systems, contributing to improved immunogenicity and efficacy in vaccine applications.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1849616-42-7 |
| Applications | Vaccine Excipient |
| Formula | (C2H4O)nC31H63NO2 |
| Molecular Weight | 542.934 |
| SMILES | CCCCCCCCCCCCCCN(C(COCCOC)=O)CCCCCCCCCCCCCC.[n] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.